MEF2C Antikörper (pSer222)
Kurzübersicht für MEF2C Antikörper (pSer222) (ABIN6254109)
Target
Alle MEF2C Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pSer222
-
Kreuzreaktivität
- Human
-
Homologie
- bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
-
Aufreinigung
- Antigen Affinity Purified from Pooled Serum
-
Immunogen
- Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- 100 μL in 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
-
Lagerung
- -20 °C
-
-
-
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
: "
-
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
-
Andere Bezeichnung
- MEF2C
-
Molekulargewicht
- '51 kDa
-
Gen-ID
- 4208
-
UniProt
- Q06413
-
Pathways
- Neurotrophin Signalübertragung, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
Target
-